OR WAIT null SECS
June 29, 2023
The persistent poverty initiative aims to fight the cumulative effects of persistent poverty on cancer outcomes.
June 27, 2023
The agency approved Elevidys to treat pediatric patients four through five years of age with Duchenne muscular dystrophy.
June 26, 2023
The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden.
The Segmentation by Exogenous Perfusion system uses a cell’s location in the tumor to find differences in gene activity.
FDA’s new draft guidance outlines key considerations for psychedelic drug development programs.
June 23, 2023
The guidance describes the CDER formal dispute resolution (FDR) procedures for eligible requestors or sponsors that wish to appeal a scientific and/or medical issue related to a final order.
June 21, 2023
The new guidelines contain formulation recommendations for vaccines launching in autumn 2023.
FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.
June 20, 2023
Researchers at the University of Waterloo have developed a liquid-liquid encapsulation system for use in sustainable encapsulation processes.
June 16, 2023
There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.